×
Alector Pre-Tax Profit Margin 2017-2025 | ALEC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Alector pre-tax profit margin from 2017 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
View More
Alector Pre-Tax Profit Margin 2017-2025 | ALEC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Alector pre-tax profit margin from 2017 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
Related Stocks
Company Name
Market
Cap
AstraZeneca (AZN)
$222.8B
Amgen (AMGN)
$162B
Gilead Sciences (GILD)
$140.6B
Vertex Pharmaceuticals (VRTX)
$118.3B
Bristol Myers Squibb (BMY)
$96.7B
CSL (CSLLY)
$85.2B
GSK (GSK)
$76.5B
Regeneron Pharmaceuticals (REGN)
$60.3B
Alnylam Pharmaceuticals (ALNY)
$42.3B
Argenex SE (ARGX)
$36.4B
BioNTech SE (BNTX)
$27.1B
Royalty Pharma (RPRX)
$20.8B
Insmed (INSM)
$19.3B
Biogen (BIIB)
$18.9B
Illumina (ILMN)
$17.4B
Genmab (GNMSF)
$15.2B
Genmab (GMAB)
$14.8B
Incyte (INCY)
$13.6B
Moderna (MRNA)
$13.1B
Exelixis (EXEL)
$12.1B
QIAGEN (QGEN)
$11.3B
BioMarin Pharmaceutical (BMRN)
$11.1B
Swedish Orphan Biovitrum (BIOVF)
$10.6B
Ascendis Pharma (ASND)
$10B
Bio-Techne Corp (TECH)
$9.2B
Exact Sciences (EXAS)
$9.1B
Verona Pharma American Depositary Share (VRNA)
$8.9B
Blueprint Medicines (BPMC)
$8.3B
Roivant Sciences (ROIV)
$7.7B
Legend Biotech (LEGN)
$7.6B